Member Info for notrac

Looking at Level 2, trades look to be duplicated but HL is recording four large trades which represent 30% of market cap, possibly a switch between institutions.

I read this as advance warning of a placing later in the month.

Over the past couple of years AIM stocks have had a bad run with the FDA (IMM, MTFB, STX). For STX and IMM it was efficacy, for MTFB safety. They are all still trying to get approval. Acknowledge that FUM is not a pure pharma product. I am sure it is safe, and I can confirm from direct experience that Cialiis and Levitra have unpleasant side effects. It would also be logical that direct application will act more quickly rather than via the blood stream. Statistically significant efficacy over the placebo will be the key.

@Maestro
You wrote yesterday "The testing is going great with no adverse side effects". How do you know that the product is meeting "to pardon the expression" the end points in the Phase III trial? Do we know how many people have now signed up?

Charting is useful for tracking the history of the SP, identifying past support and resistance levels, but is of little use on AIM where the price is mostly event driven allied with an absence of constantly loyal institutional support.

LODH made no sales last year between April and September. Cumulative net investment (purchases less disposals) now down to between £9 and £10 million. The company's MCAP is too small for other institutions.

He has form. I have seen him somewhere else, possibly ELA.

Usually FUM pull a nasty rabbit out of the hat shortly before release of the financials. Thankfully this time they have not.

Clearly TLW are out of practice on announcements re dividends: four attempts so far.

There was clearly a ramping exercise earlier in the month which took the sp to £1. Good to get additional funds at this price. I hope this is used solely in Guyana. Reduces the risk. News from JOG yesterday was a reminder of the risks in oil exporation.

Financial results are due on Wed. There was a large buy this morning. Float is small. Perhaps they have discovered a leak.

My initial research suggests that this company will manufacture, deal with suppliers and customers, with the consequential requirement on working capital. No sign of the the gross margin on the product? Did they consider licensing it out?

Three possibilities: FUM is the weekly selection of the Pump and Dump brigade; someone on the Phase 3 trial has publicised that the product works; or impending news on TPR 100.

FTSE Russell confirm that PHNX and Just Eat will be leaving FTSE 250 and joining FTSE100.

Closed at 135.85. IMO weekly chart of ITV is looking good.

Could we please stay on topic.

MoneyAM had a good charting package, although data integrity could be a bit hit and miss. Now using the charts on Advfn. For trade history, I use Level 2.

Will

While management be forced to issue a statement?

Still reducing but this time the SP took it in its stride.